NOVYY MEZhDUNARODNYY (KIOTSKIY) KONSENSUS PO VEDENIYu PATsIENTOV S GASTRITOM


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article analyzes some aspects of the new international consensus on the management of patients with gastritis. A new classification of gastritis is presented; it indicates the possibility of development of inflammation in the stomach as a result of action not only Helicobacter pylori, but also other microorganisms. The article comments the provisions of guideline aimed to feasibility of serological screening of precancerous changes, the effectiveness of morphological methods in predicting the development of stomach cancer, the use of H. pylori eradication for the prevention of stomach cancer.

全文:

受限制的访问

参考

  1. Malfertheiner P., Chan F.K., McColl K.E. Peptic ulcer disease. Lancet. 2009; 374(9699): 1449-61.
  2. Graham D.Y. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015; 148(4): 719-31.
  3. Sugano K., Tack J., Kuipers E.J., Graham D.Y., El-Omar E.M., Miura S., Haruma K., Asaka M., Uemura N., Malfertheiner P. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64: 1-15. [Epub ahead of print].
  4. Tsukanov V.V., Butorin N.N., Maady A.S., Shtygasheva O.V., Amelchugova O.S., Tonkikh J.L., Fassan M., Rugge M. Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia. Helicobacter. 2011; 16(2): 107-12.
  5. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001; 345(11): 784-89.
  6. Rugge M., Genta R.M. Staging and grading of chronic gastritis. Hum. Pathol. 2005; 36(3): 228-33.
  7. de Vries A.C., van Grieken N.C., Looman C.W., Casparie M.K., de Vries E., Meijer G.A., Kuipers E.J. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterol. 2008; 134(4): 945-52.
  8. Rugge M., de Boni M., Pennelli G., de Bona M., Giacomelli L., Fassan M., Basso D., Plebani M., Graham D.Y. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol. Ther. 2010; 31(10): 1104-11.
  9. Rugge M., Fassan M., Pizzi M., Farinati F., Sturniolo G.C., Plebani M., Graham D.Y. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J. Gastroenterol. 2011; 17(41): 4596-601.
  10. Watabe H., Mitsushima T., Yamaji Y., et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005; 54(6): 764-68.
  11. Цуканов В.В., Третьякова О.В., Амельчугова О.С., Каспаров Э.В., Родина Д.В., Васютин А.В., Буторин Н.Н., Тонких Ю.Л. Распространенность атрофического гастрита тела желудка у населения г. Красноярска старше 45 лет. Рос. журн. гастроэнтерол. гепатол., колопроктол. 2012; 4: 27-31.
  12. Цуканов В.В., Амельчугова О.С., Васютин А.В., Буторин Н.Н. Тактика ведения пациентов с предраковыми изменениями в желудке. Рос. журнал гастроэнтерол., гепатол., колопроктол. 2013; 3: 4-8.
  13. Megraud F., Coenen S., Versporten A., Kist M., Lopez-Brea M., Hirschl A.M., Andersen L.P., Goossens H. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013; 62(1): 34-42.
  14. Graham D.Y., Lee Y.C., Wu M.S. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin. Gastroenterol. Hepatol. 2014; 12(2): 177-86.
  15. Цуканов В.В., Амельчугова О.С., Буторин Н.Н., Третьякова О.В., Васютин А.В. Современные аспекты эрадикации Helicobacter pylori. Тер. архив. 2013; 2: 73-5.
  16. Ивашкин В.Т., Маев И.В., Лапина Т.Л. Шептулин А.А. Рекомендации Российской Гастроэнтерологической Ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Рос. журнал гастроэнтерол., гепатол., колопроктол. 2012; 1: 87-9.
  17. McNicholl A.G., Linares P.M., Nyssen O.P., Calvet X., Gisbert J.P. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2012; 36(5): 414-25.
  18. Gisbert J.P., Romano M., Gravina A.G., Solis-Munoz P., Bermejo F., Molina-Infante J., Castro-Fernandez M., Ortuno J., Lucendo A.J., Herranz M., Modolell I., del Castillo F., Gomez J., Barrio J., Velayos B., Gomez B., Dominguez J.L., Miranda A., Martorano M., Algaba A., Pabon M., Angueira T., Fernandez-Salazar L., Federico A., Marin A.C., McNicholl A.G. Helicobacter pylori second-line rescue therapy with levofloxacin-and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment. Pharmacol. Ther. 2015; 41(8): 768-75.
  19. Tyakht A.V., Kostryukova E.S., Popenko A.S., Belenikin M.S., Pavlenko A.V., Larin A.K., Karpova I.Y., Selezneva O.V., Semashko T.A., Ospanova E.A., Babenko V.V., Maev I.V., Cheremushkin S.V., Kucheryavyy Y.A., Shcherbakov P.L., Grinevich V.B., Efimov O.I., Sas E.I., Abdulkhakov R.A., Abdulkhakov S.R., Lyalyukova E.A., Livzan M.A., Vlassov V.V., Sagdeev R.Z., Tsukanov V.V., Osipenko M.F., Kozlova I.V., Tkachev A.V., Sergienko V.I., Alexeev D.G., Govorun V.M. Human gut microbiota community structures in urban and rural populations in Russia. Nat. Commun. 2013; 4: 2469.
  20. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E.J. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007; 56(6): 772-81.
  21. Цуканов В.В., Амельчугова О.С., Каспаров Э.В., Буторин Н.Н., Васютин А.В., Тонких Ю.Л., Третьякова О.В. Роль эрадикации Helicobacter pylori в профилактике рака желудка. Тер. архив. 2014; 8: 124-7.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2015